Zonagen Loses ED Drug Partner, Submits One-Year Study Results July 16, 2002 By Aaron Lorenzo No Comments
BioCryst Trims Staff, Changes Focus To Earlier-Stage Programs July 12, 2002 By Aaron Lorenzo No Comments
BioCryst Trims Staff, Changes Focus To Earlier-Stage Programs July 12, 2002 By Aaron Lorenzo No Comments
Celera Diagnostics, Abbott Align For In Vitro Molecular Diagnostics June 26, 2002 By Aaron Lorenzo No Comments
Celera Diagnostics, Abbott Align For In Vitro Molecular Diagnostics June 26, 2002 By Aaron Lorenzo No Comments
Proteome Sciences Paying £12.6M For Aventis' Proteomics Division June 5, 2002 By Aaron Lorenzo No Comments